Every researcher at Penn Medicine's Abramson Cancer Center is dedicated to only one purpose: the eradication of cancer as a cause of human disease and suffering. Every day, they uncover the secrets behind the causes of cancer as well as better ways to detect and treat cancer. From its beginnings, Penn Medicine's Abramson Cancer Center has been on the cutting edge of designing novel treatments for all types of cancer.
Penn Medicine's Abramson Cancer Center was established in 1973 when a small group of dedicated cancer specialists founded Penn Medicine's Abramson Cancer Center. Building on our rich history of cancer research, including pioneering discoveries such as the Philadelphia chromosome, this small group has grown to include highly respected medical, surgical and radiation oncologists, scientists, specialized nurses and many other dedicated cancer care providers offering patients new, innovative treatments in an integrated, compassionate environment.
That mission was strengthened in 1998 when the Abramson family made a $100 million commitment to support compassionate, comprehensive cancer research and care at Penn. Today, due to the ongoing philanthropic support of the Abramson family and many other dedicated grateful families, Penn Medicine's Abramson Cancer Center is an internationally renowned cancer center.
Our cancer specialists are committed to advancing ground-breaking therapies and relieving the suffering cancer can bring to patients, their families, and their friends. Their vital work received a significant boost with the opening of the Ruth and Raymond Perelman Center for Advanced Medicine, the Roberts Proton Therapy Center, and the Smilow Center for Translational Research.
Visit PennMedicine.org/Abramson for more information about their mission to provide the most advanced cancer research, patient care, and education to patients and families.
To learn more about Penn Medicine's Abramson Cancer Center's tradition of innovation in life-saving therapies, download this PDF.